HROW Q2 2020 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$8M-40.4% YoY

Gross Profit

$5M60.2% margin

Operating Income

-$3M-39.8% margin

Net Income

-$237,000-2.9% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-31.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$49M

Total Liabilities

$34M

Stockholders' Equity

$16M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$14M	-40.4%
Gross Profit	$5M	$8M	-41.4%
Operating Income	-$3M	-$767,000	-318.5%
Net Income	-$237,000	-$2M	+90.0%

Revenue Segments

License Revenues

$11,000100%